

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.97455151 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.97455151 |
| 3 | response to peptidoglycan (GO:0032494) | 4.47023824 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.43785733 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43785733 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.43785733 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43785733 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43785733 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43785733 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31723900 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26710061 |
| 12 | positive regulation of heat generation (GO:0031652) | 4.22665686 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.19203681 |
| 14 | regulation of fever generation (GO:0031620) | 4.16486880 |
| 15 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.06654777 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.02386699 |
| 17 | cellular extravasation (GO:0045123) | 3.99738691 |
| 18 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.92582813 |
| 19 | response to muramyl dipeptide (GO:0032495) | 3.85987165 |
| 20 | NIK/NF-kappaB signaling (GO:0038061) | 3.71292685 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66516735 |
| 22 | neutrophil mediated immunity (GO:0002446) | 3.61195087 |
| 23 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.58831511 |
| 24 | regulation of podosome assembly (GO:0071801) | 3.58261211 |
| 25 | leukocyte aggregation (GO:0070486) | 3.55873501 |
| 26 | tolerance induction (GO:0002507) | 3.53527171 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.52335067 |
| 28 | microglial cell activation (GO:0001774) | 3.47356542 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.44162893 |
| 30 | macrophage activation (GO:0042116) | 3.43658909 |
| 31 | granulocyte activation (GO:0036230) | 3.42850273 |
| 32 | regulation of chemokine biosynthetic process (GO:0045073) | 3.42312440 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.42111706 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.36765059 |
| 35 | response to interleukin-15 (GO:0070672) | 3.36601242 |
| 36 | dendritic cell migration (GO:0036336) | 3.34904488 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.33600184 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32629619 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.31882046 |
| 40 | regulation of regulatory T cell differentiation (GO:0045589) | 3.31143639 |
| 41 | positive regulation of interferon-alpha production (GO:0032727) | 3.28977422 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28002418 |
| 43 | interferon-gamma secretion (GO:0072643) | 3.27514450 |
| 44 | neutrophil activation (GO:0042119) | 3.26569129 |
| 45 | detection of other organism (GO:0098543) | 3.25914603 |
| 46 | regulation of vitamin metabolic process (GO:0030656) | 3.25478520 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23697559 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23101764 |
| 49 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.21619929 |
| 50 | regulation of heat generation (GO:0031650) | 3.21458877 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.21400840 |
| 52 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.18935501 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18526583 |
| 54 | dendritic cell chemotaxis (GO:0002407) | 3.18189885 |
| 55 | cytokine secretion (GO:0050663) | 3.18066904 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.18024787 |
| 57 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.17725843 |
| 58 | response to host immune response (GO:0052572) | 3.17681394 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17681394 |
| 60 | T-helper 1 type immune response (GO:0042088) | 3.15894199 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 3.10801130 |
| 62 | regulation of RIG-I signaling pathway (GO:0039535) | 3.10736409 |
| 63 | superoxide anion generation (GO:0042554) | 3.08208891 |
| 64 | detection of bacterium (GO:0016045) | 3.06812210 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.06255184 |
| 66 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04186375 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.03858139 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03756624 |
| 69 | regulation of activation of Janus kinase activity (GO:0010533) | 3.03695260 |
| 70 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.03286533 |
| 71 | positive regulation of interleukin-17 production (GO:0032740) | 3.02393584 |
| 72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01185843 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.00962376 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 3.00854778 |
| 75 | natural killer cell mediated immunity (GO:0002228) | 2.99841592 |
| 76 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.99841592 |
| 77 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99301196 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 2.97375207 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93793393 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92995233 |
| 81 | response to host (GO:0075136) | 2.92995233 |
| 82 | response to host defenses (GO:0052200) | 2.92995233 |
| 83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90940859 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.88753035 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.88165805 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87732797 |
| 87 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87598472 |
| 88 | germinal center formation (GO:0002467) | 2.84417311 |
| 89 | myeloid leukocyte mediated immunity (GO:0002444) | 2.81929873 |
| 90 | T-helper cell differentiation (GO:0042093) | 2.81563818 |
| 91 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.81563818 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.81365432 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81166385 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80989784 |
| 95 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.78913551 |
| 96 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.78233997 |
| 97 | negative regulation of B cell mediated immunity (GO:0002713) | 2.78233997 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.77418544 |
| 99 | negative regulation of humoral immune response (GO:0002921) | 2.77048380 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.76838031 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.76412491 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76412491 |
| 103 | negative thymic T cell selection (GO:0045060) | 2.74672691 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74544661 |
| 105 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.74396599 |
| 106 | respiratory burst (GO:0045730) | 2.72948400 |
| 107 | positive regulation of interleukin-2 production (GO:0032743) | 2.72842760 |
| 108 | negative T cell selection (GO:0043383) | 2.72816760 |
| 109 | regulation of mast cell activation (GO:0033003) | 2.71740863 |
| 110 | regulation of interleukin-12 production (GO:0032655) | 2.71694619 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.70228448 |
| 112 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.69512773 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68884322 |
| 114 | iron ion import (GO:0097286) | 2.68685429 |
| 115 | regulation of germinal center formation (GO:0002634) | 2.68338624 |
| 116 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67693809 |
| 117 | hepatocyte apoptotic process (GO:0097284) | 2.67422391 |
| 118 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67203476 |
| 119 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67087512 |
| 120 | leukocyte mediated cytotoxicity (GO:0001909) | 2.66370315 |
| 121 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.65891261 |
| 122 | leukocyte degranulation (GO:0043299) | 2.65123155 |
| 123 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64842782 |
| 124 | negative regulation of protein autophosphorylation (GO:0031953) | 2.64832403 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 2.64222907 |
| 126 | regulation of leukocyte degranulation (GO:0043300) | 2.64043307 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63896597 |
| 128 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.63013580 |
| 129 | defense response to protozoan (GO:0042832) | 2.63003065 |
| 130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62745979 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.62697389 |
| 132 | T cell activation involved in immune response (GO:0002286) | 2.62391137 |
| 133 | negative regulation of adaptive immune response (GO:0002820) | 2.61967752 |
| 134 | leukocyte cell-cell adhesion (GO:0007159) | 2.60949686 |
| 135 | regulation of chronic inflammatory response (GO:0002676) | 2.60779138 |
| 136 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.60531319 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60434179 |
| 138 | positive thymic T cell selection (GO:0045059) | 2.59951403 |
| 139 | positive regulation of interleukin-6 production (GO:0032755) | 2.59795252 |
| 140 | response to type I interferon (GO:0034340) | 2.59740744 |
| 141 | regulation of B cell differentiation (GO:0045577) | 2.58726242 |
| 142 | reactive oxygen species biosynthetic process (GO:1903409) | 2.58536090 |
| 143 | response to protozoan (GO:0001562) | 2.58461727 |
| 144 | surfactant homeostasis (GO:0043129) | 2.58306313 |
| 145 | type I interferon signaling pathway (GO:0060337) | 2.58189351 |
| 146 | cellular response to type I interferon (GO:0071357) | 2.58189351 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 2.57681922 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.56491181 |
| 149 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.55396400 |
| 150 | regulation of interleukin-17 production (GO:0032660) | 2.54049049 |
| 151 | B cell mediated immunity (GO:0019724) | 2.54001106 |
| 152 | positive regulation of type 2 immune response (GO:0002830) | 2.53918857 |
| 153 | regulation of prostaglandin secretion (GO:0032306) | 2.53817758 |
| 154 | monocyte chemotaxis (GO:0002548) | 2.52726573 |
| 155 | intestinal epithelial cell development (GO:0060576) | 2.52135050 |
| 156 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.51811900 |
| 157 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51769623 |
| 158 | regulation of antigen processing and presentation (GO:0002577) | 2.51156085 |
| 159 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.50637437 |
| 160 | myeloid dendritic cell activation (GO:0001773) | 2.50432468 |
| 161 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49896294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.86350545 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.82664955 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57283603 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.45062236 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46015498 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.45001065 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.27526654 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02814370 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99300598 |
| 10 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.99129626 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.98447190 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98034292 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.96033267 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88253571 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73355038 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69997946 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58778865 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56408045 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.53096390 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.49009995 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32291761 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.27594586 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11654926 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.11426151 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89100056 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77301474 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76173342 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76113976 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73723635 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67539237 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.64421176 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.64117893 |
| 33 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62993643 |
| 34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62993643 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.60687632 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56437995 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.53225221 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51624188 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51319973 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50468833 |
| 41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.50439921 |
| 42 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49985223 |
| 43 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.45836260 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44422975 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44259820 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.44146723 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.43686731 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.43686731 |
| 49 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.43686731 |
| 50 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43072156 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42131491 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41581779 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39826725 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.39702552 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35971423 |
| 56 | * MAF_26560356_Chip-Seq_TH1_Human | 1.35547275 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34857702 |
| 58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32370732 |
| 59 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31357671 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30823274 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30130152 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29918467 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28428273 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27915875 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27371975 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26981487 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26604705 |
| 68 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26055247 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25636851 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24993245 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24816075 |
| 72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.22842109 |
| 73 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22664657 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22551074 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22052218 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19331497 |
| 77 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17678696 |
| 78 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17656037 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16947775 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16032813 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15572561 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15233819 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14894451 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12817769 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11153277 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10866138 |
| 87 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07868991 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07580485 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03975062 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03486844 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02515518 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02334865 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01529404 |
| 94 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01413604 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01162079 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00960256 |
| 97 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00777094 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00668188 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00383258 |
| 100 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99996867 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99340894 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98970732 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98899461 |
| 104 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98823715 |
| 105 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98164075 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97855859 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96548919 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94989279 |
| 109 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94340119 |
| 110 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94317301 |
| 111 | * MAF_26560356_Chip-Seq_TH2_Human | 0.93689637 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89542352 |
| 113 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88726225 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88531626 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87963470 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87541556 |
| 117 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.87204345 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85379804 |
| 119 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85339170 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84238302 |
| 121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83831299 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83082349 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83017264 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82656534 |
| 125 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82409356 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82364782 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82166665 |
| 128 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81774890 |
| 129 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.80993086 |
| 130 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.80036332 |
| 131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79417113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 3.36321570 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.06745375 |
| 3 | MP0003436_decreased_susceptibility_to | 2.83499234 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.73164291 |
| 5 | MP0003724_increased_susceptibility_to | 2.62513718 |
| 6 | MP0004947_skin_inflammation | 2.52229772 |
| 7 | MP0003303_peritoneal_inflammation | 2.49578575 |
| 8 | MP0000685_abnormal_immune_system | 2.44493907 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.43370441 |
| 10 | MP0002419_abnormal_innate_immunity | 2.41114815 |
| 11 | MP0005025_abnormal_response_to | 2.40037503 |
| 12 | MP0005387_immune_system_phenotype | 2.32940806 |
| 13 | MP0001790_abnormal_immune_system | 2.32940806 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.23124017 |
| 15 | MP0002254_reproductive_system_inflammat | 2.19820670 |
| 16 | MP0006082_CNS_inflammation | 2.19089982 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.14819222 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.13706226 |
| 19 | MP0004782_abnormal_surfactant_physiolog | 2.04857778 |
| 20 | MP0002723_abnormal_immune_serum | 2.00866786 |
| 21 | MP0009278_abnormal_bone_marrow | 1.99185730 |
| 22 | MP0004381_abnormal_hair_follicle | 1.99161043 |
| 23 | MP0002006_tumorigenesis | 1.97503705 |
| 24 | MP0001800_abnormal_humoral_immune | 1.96990044 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.95586416 |
| 26 | MP0002405_respiratory_system_inflammati | 1.91709213 |
| 27 | MP0005671_abnormal_response_to | 1.87835369 |
| 28 | MP0009764_decreased_sensitivity_to | 1.86711556 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.86074764 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.85871119 |
| 31 | MP0001819_abnormal_immune_cell | 1.82955382 |
| 32 | MP0005310_abnormal_salivary_gland | 1.81169359 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.78431638 |
| 34 | MP0005083_abnormal_biliary_tract | 1.76718463 |
| 35 | MP0003448_altered_tumor_morphology | 1.72861629 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.68641757 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.67790832 |
| 38 | MP0001873_stomach_inflammation | 1.67329524 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.65521424 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.61697474 |
| 41 | MP0004510_myositis | 1.59086459 |
| 42 | MP0000858_altered_metastatic_potential | 1.57864396 |
| 43 | MP0004883_abnormal_blood_vessel | 1.57543875 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.54117974 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.53441741 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.52434689 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.50972217 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.50972217 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.50300284 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.48389900 |
| 51 | MP0002009_preneoplasia | 1.46062825 |
| 52 | MP0001853_heart_inflammation | 1.45383446 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.44168200 |
| 54 | MP0003941_abnormal_skin_development | 1.36239257 |
| 55 | MP0000490_abnormal_crypts_of | 1.36160983 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.29805725 |
| 57 | MP0000716_abnormal_immune_system | 1.29342652 |
| 58 | MP0002796_impaired_skin_barrier | 1.29082381 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.27140876 |
| 60 | MP0003828_pulmonary_edema | 1.25204248 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.24976913 |
| 62 | MP0008469_abnormal_protein_level | 1.24401631 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.23846218 |
| 64 | MP0003878_abnormal_ear_physiology | 1.23846218 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.22568498 |
| 66 | MP0003866_abnormal_defecation | 1.22350637 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.20341329 |
| 68 | MP0002398_abnormal_bone_marrow | 1.19892856 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.17580989 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.17189647 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.16492315 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 1.12331222 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 1.11507648 |
| 74 | MP0002132_abnormal_respiratory_system | 1.11013391 |
| 75 | MP0010678_abnormal_skin_adnexa | 1.08565698 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.08182643 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.07929485 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.07070986 |
| 79 | MP0005166_decreased_susceptibility_to | 1.06744568 |
| 80 | MP0000343_altered_response_to | 1.06591419 |
| 81 | MP0002429_abnormal_blood_cell | 1.05234659 |
| 82 | MP0003045_fibrosis | 1.03800411 |
| 83 | MP0003693_abnormal_embryo_hatching | 1.02691936 |
| 84 | MP0002396_abnormal_hematopoietic_system | 1.01512004 |
| 85 | MP0000703_abnormal_thymus_morphology | 1.01460618 |
| 86 | MP0002722_abnormal_immune_system | 1.00995919 |
| 87 | MP0005365_abnormal_bile_salt | 0.99173047 |
| 88 | MP0000627_abnormal_mammary_gland | 0.98873215 |
| 89 | MP0000383_abnormal_hair_follicle | 0.98768163 |
| 90 | MP0008004_abnormal_stomach_pH | 0.98455425 |
| 91 | MP0009840_abnormal_foam_cell | 0.95948792 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.95768881 |
| 93 | MP0005451_abnormal_body_composition | 0.94550951 |
| 94 | MP0001881_abnormal_mammary_gland | 0.93092113 |
| 95 | MP0008995_early_reproductive_senescence | 0.92100298 |
| 96 | MP0003646_muscle_fatigue | 0.91314224 |
| 97 | MP0003075_altered_response_to | 0.90594432 |
| 98 | MP0005164_abnormal_response_to | 0.87593760 |
| 99 | MP0010307_abnormal_tumor_latency | 0.87051841 |
| 100 | MP0005023_abnormal_wound_healing | 0.86731273 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.86370076 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.85824574 |
| 103 | MP0003186_abnormal_redox_activity | 0.83716665 |
| 104 | MP0002136_abnormal_kidney_physiology | 0.83707844 |
| 105 | MP0008057_abnormal_DNA_replication | 0.81948439 |
| 106 | MP0003252_abnormal_bile_duct | 0.81902409 |
| 107 | MP0005390_skeleton_phenotype | 0.81425449 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.81068831 |
| 109 | MP0008260_abnormal_autophagy | 0.80583742 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.78480369 |
| 111 | MP0001663_abnormal_digestive_system | 0.77254552 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.76458559 |
| 113 | MP0001851_eye_inflammation | 0.75878061 |
| 114 | MP0001191_abnormal_skin_condition | 0.75615003 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.75513350 |
| 116 | MP0002060_abnormal_skin_morphology | 0.75362506 |
| 117 | MP0000470_abnormal_stomach_morphology | 0.75089367 |
| 118 | MP0000371_diluted_coat_color | 0.74774248 |
| 119 | MP0000427_abnormal_hair_cycle | 0.74728552 |
| 120 | MP0004484_altered_response_of | 0.73893310 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.73476794 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.73090398 |
| 123 | MP0005501_abnormal_skin_physiology | 0.73024048 |
| 124 | MP0004019_abnormal_vitamin_homeostasis | 0.72227240 |
| 125 | MP0009763_increased_sensitivity_to | 0.72128721 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.71968149 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.71756597 |
| 128 | MP0000609_abnormal_liver_physiology | 0.66588859 |
| 129 | MP0000377_abnormal_hair_follicle | 0.65803163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.00438698 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.45050258 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.92860623 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.71562488 |
| 5 | Optic neuritis (HP:0100653) | 4.71562488 |
| 6 | Orchitis (HP:0100796) | 4.70331502 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.34247285 |
| 8 | Stomatitis (HP:0010280) | 4.20439108 |
| 9 | Myositis (HP:0100614) | 4.14803511 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.13016265 |
| 11 | Pustule (HP:0200039) | 4.12273316 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.06125170 |
| 13 | Interstitial pulmonary disease (HP:0006530) | 3.93747519 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.63499460 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.63018819 |
| 16 | Gingivitis (HP:0000230) | 3.62201441 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.60291942 |
| 18 | Prostate neoplasm (HP:0100787) | 3.36987197 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.21375256 |
| 20 | Vasculitis (HP:0002633) | 3.20213016 |
| 21 | Periodontitis (HP:0000704) | 3.14485509 |
| 22 | Cheilitis (HP:0100825) | 2.99149173 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96073932 |
| 24 | Obstructive lung disease (HP:0006536) | 2.96073932 |
| 25 | Recurrent skin infections (HP:0001581) | 2.94957676 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 2.93188415 |
| 27 | Keratoconjunctivitis (HP:0001096) | 2.92975503 |
| 28 | Premature loss of primary teeth (HP:0006323) | 2.90822171 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.88255195 |
| 30 | Thick nail (HP:0001805) | 2.85990647 |
| 31 | Increased IgE level (HP:0003212) | 2.85174366 |
| 32 | Malnutrition (HP:0004395) | 2.79967020 |
| 33 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.77275796 |
| 34 | Alveolar cell carcinoma (HP:0006519) | 2.76091134 |
| 35 | Absent/shortened dynein arms (HP:0200106) | 2.70665204 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.70665204 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.67272854 |
| 38 | Recurrent viral infections (HP:0004429) | 2.64760623 |
| 39 | Bronchiectasis (HP:0002110) | 2.64182789 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.62853081 |
| 41 | T lymphocytopenia (HP:0005403) | 2.60994839 |
| 42 | Chronic bronchitis (HP:0004469) | 2.56703538 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.55547717 |
| 44 | Bronchitis (HP:0012387) | 2.53822676 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.51842084 |
| 46 | Hemoptysis (HP:0002105) | 2.47314794 |
| 47 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.46986325 |
| 48 | Increased IgM level (HP:0003496) | 2.45846883 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45561203 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45561203 |
| 51 | Tetraparesis (HP:0002273) | 2.44779620 |
| 52 | Anorexia (HP:0002039) | 2.44705891 |
| 53 | Urticaria (HP:0001025) | 2.43112456 |
| 54 | Arterial thrombosis (HP:0004420) | 2.42987235 |
| 55 | Hypochromic anemia (HP:0001931) | 2.41414269 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.40568562 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.40546106 |
| 58 | Chronic sinusitis (HP:0011109) | 2.38756720 |
| 59 | Plantar hyperkeratosis (HP:0007556) | 2.37931519 |
| 60 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.34195166 |
| 61 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.34195166 |
| 62 | Chest pain (HP:0100749) | 2.33641995 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.31722368 |
| 64 | Hematochezia (HP:0002573) | 2.31650842 |
| 65 | Leukocytosis (HP:0001974) | 2.30879181 |
| 66 | Abnormality of T cells (HP:0002843) | 2.27871214 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.26472755 |
| 68 | Abnormal ciliary motility (HP:0012262) | 2.24533958 |
| 69 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.24331489 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.23621686 |
| 71 | Esophageal varix (HP:0002040) | 2.23014527 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21591777 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.21591777 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.18794689 |
| 75 | Petechiae (HP:0000967) | 2.16380043 |
| 76 | Onycholysis (HP:0001806) | 2.16228346 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.15714400 |
| 78 | Gangrene (HP:0100758) | 2.15562965 |
| 79 | Palmar hyperkeratosis (HP:0010765) | 2.14503269 |
| 80 | Episodic fever (HP:0001954) | 2.13049806 |
| 81 | Pulmonary embolism (HP:0002204) | 2.13031277 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09473966 |
| 83 | Palmoplantar hyperkeratosis (HP:0000972) | 2.09429805 |
| 84 | Lip pit (HP:0100267) | 2.08308714 |
| 85 | Meningitis (HP:0001287) | 2.07629125 |
| 86 | Rhinitis (HP:0012384) | 2.06927156 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.05862652 |
| 88 | Osteomyelitis (HP:0002754) | 2.04492202 |
| 89 | Stomach cancer (HP:0012126) | 2.03687136 |
| 90 | Cellulitis (HP:0100658) | 2.02810524 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 2.00201284 |
| 92 | Chronic otitis media (HP:0000389) | 1.99838809 |
| 93 | Hyperkalemia (HP:0002153) | 1.98302717 |
| 94 | Increased cerebral lipofuscin (HP:0011813) | 1.98270065 |
| 95 | Skin ulcer (HP:0200042) | 1.97871735 |
| 96 | Ventricular fibrillation (HP:0001663) | 1.97611293 |
| 97 | Anhidrosis (HP:0000970) | 1.97057498 |
| 98 | Granulocytopenia (HP:0001913) | 1.91724928 |
| 99 | Colitis (HP:0002583) | 1.91562432 |
| 100 | Peritonitis (HP:0002586) | 1.91295591 |
| 101 | Chronic diarrhea (HP:0002028) | 1.89368396 |
| 102 | IgA deficiency (HP:0002720) | 1.89030431 |
| 103 | Abnormality of the pericardium (HP:0001697) | 1.88998516 |
| 104 | Amyloidosis (HP:0011034) | 1.88285347 |
| 105 | Basal ganglia calcification (HP:0002135) | 1.87601385 |
| 106 | Microcytic anemia (HP:0001935) | 1.87088820 |
| 107 | Abnormality of the nasal septum (HP:0000419) | 1.86354602 |
| 108 | Gingival bleeding (HP:0000225) | 1.85045709 |
| 109 | Curly hair (HP:0002212) | 1.83406010 |
| 110 | Abnormality of the gastric mucosa (HP:0004295) | 1.83244066 |
| 111 | Milia (HP:0001056) | 1.83179438 |
| 112 | Increased CSF protein (HP:0002922) | 1.82924404 |
| 113 | Micronodular cirrhosis (HP:0001413) | 1.82697597 |
| 114 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81510418 |
| 115 | Recurrent pneumonia (HP:0006532) | 1.81265090 |
| 116 | Acne (HP:0001061) | 1.81074329 |
| 117 | Abnormality of the prostate (HP:0008775) | 1.80660590 |
| 118 | Recurrent otitis media (HP:0000403) | 1.80311617 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.79959950 |
| 120 | Abnormality of T cell number (HP:0011839) | 1.79282178 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.79261869 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.79261869 |
| 123 | Encephalitis (HP:0002383) | 1.78435664 |
| 124 | Blepharitis (HP:0000498) | 1.76093509 |
| 125 | Alopecia of scalp (HP:0002293) | 1.74829745 |
| 126 | Eosinophilia (HP:0001880) | 1.74205647 |
| 127 | Right ventricular cardiomyopathy (HP:0011663) | 1.74076123 |
| 128 | Bone pain (HP:0002653) | 1.73828088 |
| 129 | Nasal polyposis (HP:0100582) | 1.72343427 |
| 130 | Abnormality of the fingertips (HP:0001211) | 1.70934159 |
| 131 | Myocardial infarction (HP:0001658) | 1.70375732 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.68171243 |
| 133 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.66566730 |
| 134 | Villous atrophy (HP:0011473) | 1.66566730 |
| 135 | Rectal prolapse (HP:0002035) | 1.66543146 |
| 136 | Hyperactive renin-angiotensin system (HP:0000841) | 1.66301985 |
| 137 | Porencephaly (HP:0002132) | 1.65571554 |
| 138 | Joint swelling (HP:0001386) | 1.64365045 |
| 139 | Abnormality of chloride homeostasis (HP:0011422) | 1.64243299 |
| 140 | Persistence of primary teeth (HP:0006335) | 1.64166692 |
| 141 | Arthralgia (HP:0002829) | 1.63403481 |
| 142 | Abnormality of eosinophils (HP:0001879) | 1.63034519 |
| 143 | Abnormality of T cell physiology (HP:0011840) | 1.62773287 |
| 144 | Polyneuropathy (HP:0001271) | 1.62716269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.79809545 |
| 2 | IRAK3 | 3.92083535 |
| 3 | MST4 | 3.33603500 |
| 4 | TBK1 | 2.77018929 |
| 5 | IRAK4 | 2.64096246 |
| 6 | EPHA2 | 2.63552240 |
| 7 | TXK | 2.61064903 |
| 8 | IKBKB | 2.47317206 |
| 9 | RIPK4 | 2.40740784 |
| 10 | IKBKE | 2.37521016 |
| 11 | MAP4K1 | 2.35513543 |
| 12 | JAK3 | 2.26097045 |
| 13 | CHUK | 2.09112448 |
| 14 | BLK | 2.06383649 |
| 15 | STK10 | 2.06292233 |
| 16 | TYK2 | 1.99818185 |
| 17 | CDK12 | 1.94971901 |
| 18 | TAOK3 | 1.91325247 |
| 19 | MST1R | 1.62207322 |
| 20 | PBK | 1.53852175 |
| 21 | EPHB1 | 1.50032020 |
| 22 | CSK | 1.42297362 |
| 23 | ERN1 | 1.40253424 |
| 24 | MAP3K3 | 1.37093527 |
| 25 | RPS6KA4 | 1.36484708 |
| 26 | STK3 | 1.34299617 |
| 27 | PIM1 | 1.34158902 |
| 28 | NUAK1 | 1.30434336 |
| 29 | AKT3 | 1.30361196 |
| 30 | JAK1 | 1.29755786 |
| 31 | FER | 1.28611485 |
| 32 | FES | 1.25454582 |
| 33 | TNK2 | 1.25090648 |
| 34 | PIM2 | 1.22282785 |
| 35 | MAP3K10 | 1.19266440 |
| 36 | BMX | 1.17808385 |
| 37 | PRPF4B | 1.15985932 |
| 38 | ZAP70 | 1.14332219 |
| 39 | TEC | 1.10933589 |
| 40 | MAP3K11 | 1.10674404 |
| 41 | MAPK15 | 1.06223103 |
| 42 | MARK3 | 1.03622353 |
| 43 | RIPK1 | 1.01196976 |
| 44 | OXSR1 | 1.00914395 |
| 45 | MAP3K7 | 0.99783196 |
| 46 | FGFR3 | 0.99617566 |
| 47 | LATS1 | 0.98916299 |
| 48 | SIK3 | 0.95405331 |
| 49 | EIF2AK2 | 0.94529782 |
| 50 | STK24 | 0.90351680 |
| 51 | SGK3 | 0.90300128 |
| 52 | PRKG2 | 0.89437919 |
| 53 | MAP2K2 | 0.89346079 |
| 54 | EPHA3 | 0.89246176 |
| 55 | BTK | 0.87769513 |
| 56 | NEK9 | 0.87623371 |
| 57 | MARK2 | 0.86971272 |
| 58 | SGK2 | 0.85280314 |
| 59 | FRK | 0.84755094 |
| 60 | MAP2K6 | 0.84639599 |
| 61 | MATK | 0.84533774 |
| 62 | TRPM7 | 0.84231270 |
| 63 | NLK | 0.84165730 |
| 64 | TRIB3 | 0.81412680 |
| 65 | HIPK2 | 0.81324729 |
| 66 | PTK6 | 0.81175534 |
| 67 | STK39 | 0.79476651 |
| 68 | HCK | 0.78369569 |
| 69 | MAP3K6 | 0.78340800 |
| 70 | FGFR4 | 0.78192982 |
| 71 | STK4 | 0.77731207 |
| 72 | KSR2 | 0.77553318 |
| 73 | MAP2K3 | 0.77137761 |
| 74 | MAP3K13 | 0.77049915 |
| 75 | ACVR1B | 0.75758705 |
| 76 | RPS6KB2 | 0.75385751 |
| 77 | PRKD2 | 0.75188238 |
| 78 | LRRK2 | 0.74190755 |
| 79 | GRK1 | 0.73744774 |
| 80 | JAK2 | 0.73139394 |
| 81 | PDPK1 | 0.73043584 |
| 82 | WNK1 | 0.70534926 |
| 83 | PDK1 | 0.68689039 |
| 84 | LCK | 0.65512461 |
| 85 | PRKCQ | 0.64366351 |
| 86 | PKN2 | 0.63876623 |
| 87 | ITK | 0.63858597 |
| 88 | CDK6 | 0.62230532 |
| 89 | FGR | 0.61686489 |
| 90 | IRAK1 | 0.60037898 |
| 91 | TGFBR2 | 0.58572977 |
| 92 | ERBB4 | 0.56200660 |
| 93 | YES1 | 0.55906963 |
| 94 | MAP3K5 | 0.55418026 |
| 95 | LYN | 0.54602955 |
| 96 | TAOK1 | 0.54246832 |
| 97 | MAPKAPK2 | 0.54117044 |
| 98 | SYK | 0.54104130 |
| 99 | ERBB2 | 0.53833155 |
| 100 | MAP3K12 | 0.52602472 |
| 101 | KIT | 0.52224461 |
| 102 | PAK3 | 0.52012838 |
| 103 | MAPKAPK3 | 0.51778805 |
| 104 | BMPR2 | 0.51452687 |
| 105 | RET | 0.50798326 |
| 106 | TLK1 | 0.50782035 |
| 107 | ABL1 | 0.50428504 |
| 108 | PIK3CG | 0.49581202 |
| 109 | PRKCI | 0.49537029 |
| 110 | PRKAA2 | 0.48461780 |
| 111 | MAP3K8 | 0.48429669 |
| 112 | RPS6KA2 | 0.46100089 |
| 113 | PAK4 | 0.45949642 |
| 114 | EPHB2 | 0.45506054 |
| 115 | SGK494 | 0.45421011 |
| 116 | SGK223 | 0.45421011 |
| 117 | EGFR | 0.45028517 |
| 118 | RPS6KL1 | 0.44773676 |
| 119 | RPS6KC1 | 0.44773676 |
| 120 | RPS6KA6 | 0.44085491 |
| 121 | STK11 | 0.43856452 |
| 122 | STK38 | 0.43368242 |
| 123 | TAOK2 | 0.42992995 |
| 124 | PRKCD | 0.42205273 |
| 125 | NEK2 | 0.41467393 |
| 126 | ZAK | 0.41362919 |
| 127 | MAP3K1 | 0.40301316 |
| 128 | GRK6 | 0.40011732 |
| 129 | RPS6KA1 | 0.38792439 |
| 130 | PDGFRB | 0.37834078 |
| 131 | MAP3K2 | 0.33218115 |
| 132 | STK38L | 0.32828967 |
| 133 | CSF1R | 0.32281177 |
| 134 | ABL2 | 0.31944550 |
| 135 | SIK1 | 0.31698811 |
| 136 | GSK3A | 0.31532186 |
| 137 | PTK2 | 0.31370816 |
| 138 | PLK4 | 0.31048245 |
| 139 | NME2 | 0.30591771 |
| 140 | MELK | 0.30340590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.21196924 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.14224175 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.98770165 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.83148165 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.63793126 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.62331850 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35277439 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.29522728 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.26852152 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.17565114 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.11950592 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02791674 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.00824595 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96400135 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.90354921 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.87707408 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86912031 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.80423268 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79407300 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76365879 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.76333183 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71895029 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.69725924 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63596938 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60908510 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.60559708 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49736140 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.45703670 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44134325 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.42633044 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42128096 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.29418242 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.29223242 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25166092 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23852265 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23280106 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.20997204 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15821591 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09261441 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02925747 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99493736 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 0.99149089 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.99096186 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98948234 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96949500 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96873781 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.96419000 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93997678 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91978250 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91071129 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89112895 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88152511 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87789482 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87447663 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85820097 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85466300 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85411321 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.84280052 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81607813 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80082299 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78181199 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78105557 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.78099110 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77267696 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77195723 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 0.75493757 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74371315 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74075545 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73686366 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72586770 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69856439 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69243632 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67303658 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66780953 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66142697 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66041271 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65744401 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65054868 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64874000 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63524378 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63250860 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62567779 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61984314 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57895465 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57006242 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55755964 |
| 87 | * Endocytosis_Homo sapiens_hsa04144 | 0.55637429 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55470020 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54750012 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54585560 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53403737 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53381691 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52812971 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51802745 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51711727 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50405351 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49290122 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48415052 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48411728 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46849963 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46813026 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46157506 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44904043 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44500280 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44289015 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41131383 |
| 107 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41083293 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38770493 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37405576 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37217297 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37135104 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36764655 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36443305 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34163569 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33722774 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.32592373 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32547367 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31342720 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.30242341 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.30219222 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.30071070 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28254281 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28223359 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27493253 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27080165 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26924288 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26825534 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26813014 |

